Notably, this adverse reaction represents only the second documented instance of anti-tumor necrosis factor-alpha (TNF-α)-induced HLP, highlighting the potential paradoxical cutaneous reactions associated with these therapies. Here, TNF is linked to hyperkeratosis lenticularis perstans.